Q32 Bio (QTTB) Non-Current Debt (2023 - 2026)
Q32 Bio (QTTB) posted quarterly Non-Current Debt of $1.9 million for Q1 2026, down 75.88% year-over-year from $8.0 million in Q1 2025, and down 44.17% quarter-over-quarter from $3.5 million in Q4 2025.
Q32 Bio (QTTB) Non-Current Debt (2023 - 2026) Analysis & Trends
Q32 Bio's Non-Current Debt history runs 4 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- In Q1 2026, Non-Current Debt fell 75.88% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (down 75.88% YoY), while the FY2025 annual figure was $3.5 million, down 63.66% from the prior year.
- Non-Current Debt for Q1 2026 stood at $1.9 million, down from $3.5 million in the prior quarter.
- The five-year high for Non-Current Debt was $12.6 million in Q2 2024, with the low at $1.9 million in Q1 2026.
- The 4-year median for Non-Current Debt is $7.3 million (2025), against an average of $7.2 million.
- The sharpest annual moves came in 2024 and 2026: Non-Current Debt soared 108.6% in 2024, then slumped 75.88% in 2026.
- Q32 Bio's Non-Current Debt stood at $4.6 million in 2023, then jumped by 108.6% to $9.6 million in 2024, then tumbled by 63.66% to $3.5 million in 2025, then slumped by 44.17% to $1.9 million in 2026.
- Business Quant data shows QTTB's Non-Current Debt at $1.9 million in Q1 2026, $3.5 million in Q4 2025, and $5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 882.16 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 8.96 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Q32 Bio | 359.61 Mn | 253.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.94 Mn |
| Dec 31, 2025 | 3.47 Mn |
| Sep 30, 2025 | 5.00 Mn |
| Jun 30, 2025 | 6.52 Mn |
| Mar 31, 2025 | 8.04 Mn |
| Dec 31, 2024 | 9.56 Mn |
| Sep 30, 2024 | 11.07 Mn |
| Jun 30, 2024 | 12.55 Mn |
| Mar 31, 2024 | 9.40 Mn |
| Dec 31, 2023 | 4.58 Mn |